Nvidia (NVDA) Stocks Faces ‘Make or Break’ Moment, Says Wolfe Research
Nvidia (NVDA) and other momentum stocks face a make or break moment as the bull market in U.S. equities shows signs of ...
Mass layoffs of federal workers could hurt families and local economies — but may not dent the overall economy
Elon Musk, wielding a chainsaw, is overseeing a rapid shrinking of the nation’s largest employer: the federal government.
Wolfe Research Downgrades Robinhood Markets (NASDAQ:HOOD) to Peer Perform
Wolfe Research lowered shares of Robinhood Markets (NASDAQ:HOOD – Free Report) from an outperform rating to a peer perform ...
Tesla (TSLA) Is the Best Stock to Short, Says Wolfe Research
Electric vehicle maker Tesla (TSLA) has been named the best stock for investors to short right now by Wolfe Research.Maximize ...
Yahoo Finance7d
Robinhood downgraded to Peer Perform from Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak downgraded Robinhood (HOOD) to Peer Perform from Outperform and removed the firm’s prior $51 price target Since the firm’s previous upgrade of the shares ...
ConsumerAffairs5d
Car insurance rates spike 60% faster if tariffs on Mexico, Canada happen, research says
Car insurance rates could rise rapidly if President Trump slaps tariffs on Canada and Mexico. Assuming a 25% tariff on the ...
Ford's CEO says Trump's tariffs are causing chaos and could be devastating to the auto industry
"So far, what we are seeing is a lot of cost and a lot of chaos," Jim Farley said of Trump's tariffs.
Yahoo Finance7d
Wolfe downgrades Datadog on growth concerns, upgrades Snowflake on improving trend
Investing.com -- Wolfe Research downgraded Datadog (NASDAQ:DDOG) to "Peer Perform" from "Outperform" on weaker-than-expected fiscal 2025 growth guidance, competitive pressures, and margin concerns.
Why the spring selling season is going to be 'challenging' for homebuilders
The spring home-selling season is shaping up to be a challenging one for major homebuilders amid a trade war and rising mortgage rates.
TipRanks on MSN5d
Illumina weakness ‘overdone,’ says Wolfe Research
Wolfe Research reiterated an Outperform rating and $150 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about its ...